Reviving Decades-Old Wisdom: Longitudinal Analysis of Renin–Angiotensin System Inhibitors and Its Effects on Acute Ischemic Stroke to Improve Outcomes

While renin-angiotensin system (RAS) inhibitors have a longstanding history in blood pressure control, their suitability as first-line in-patient treatment may be limited due to prolonged half-life and kidney failure concerns.